Generate Biomedicines, Inc. filed 11 H-1B LCAs in FY2025. Average salary: $188k.
Generate Biomedicines, Inc. sponsored 11 H-1B positions during the FY FY2025 cycle, offering an average of $188k. Top positions include Senior Research Associate (18%), Executive Director, Application Development (9%), Senior Vice President, Strategy and Business Development (9%). Filings were concentrated in Massachusetts (91%), California (9%). The certification rate was 100%. Salaries ranged from $90k to $416k.
| Percentile | Salary |
|---|---|
| 10th | $92k |
| 25th | $115k |
| 50th (Median) | $145k |
| 75th | $304k |
| 90th | $310k |
Based on 11 salary records. Range: $90k – $416k.
100% of filings offer salaries above the prevailing wage, with an average premium of 34.1%. The average prevailing wage is $136k (based on 11 filings).
Average processing time is 7 days (median: 7 days). Fastest: 7 days, slowest: 8 days. Based on 11 filings.
36% of filings are for new positions, while 9% are for continued employment (11 filings).
Average contract duration: 33 months (median: 36 months), based on 11 filings.
| Visa Class | Filings |
|---|---|
| H-1B | 7 |
| E-3 AUSTRALIAN | 3 |
| H-1B1 SINGAPORE | 1 |
| Education Level | Filings |
|---|---|
| Not Specified | 11 |
| Job Title | Filings |
|---|---|
| Senior Research Associate | 2 |
| Executive Director, Application Development | 1 |
| Senior Vice President, Strategy and Business Development | 1 |
| Scientist I, Machine Learning | 1 |
| Scientist I | 1 |
| Senior Scientist I | 1 |
| Software Engineer III | 1 |
| Executive Director, Machine Learning Engineering | 1 |
| Scientist II | 1 |
| Engineer III, Computational Biology | 1 |
Generate Biomedicines, Inc. filed 11 H-1B Labor Condition Applications (LCAs) in FY2025.
The average H-1B salary at Generate Biomedicines, Inc. in FY2025 was $188k.
The top H-1B job titles sponsored by Generate Biomedicines, Inc. in FY2025 include Senior Research Associate, Executive Director, Application Development, Senior Vice President, Strategy and Business Development.